{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:01:51Z","timestamp":1772949711710,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101008548"],"award-info":[{"award-number":["101008548"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","award":["741-rcr2013-71"],"award-info":[{"award-number":["741-rcr2013-71"]}],"id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijpt.2025.101200","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T06:46:59Z","timestamp":1755154019000},"page":"101200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Long-Term Tumor Control After Carbon Ion Radiation Therapy Boost in Locally Advanced Cervical Clear Cell Adenocarcinoma"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-104X","authenticated-orcid":false,"given":"Amelia","family":"Barcellini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Vai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Imparato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durim","family":"Delishaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Pietro","family":"Soatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Tinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpt.2025.101200_bib1","unstructured":"Cue L., Martingano D.J., Mahdy H. Clear Cell Carcinoma of the Cervix. In: StatPearls. StatPearls Publishing; 2025. Accessed May 12, 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546591\/."},{"key":"10.1016\/j.ijpt.2025.101200_bib2","first-page":"S90","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix","volume":"24","author":"Hasegawa","year":"2014","journal-title":"Int\u00a0J\u00a0Gynecol\u00a0Cancer"},{"issue":"5","key":"10.1016\/j.ijpt.2025.101200_bib3","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1097\/MPH.0b013e318257dc91","article-title":"Successful treatment of an adolescent with locally advanced cervicovaginal clear cell adenocarcinoma using definitive chemotherapy and radiotherapy","volume":"34","author":"Ansari","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2025.101200_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1525-1438.2007.01037.x","article-title":"A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix","volume":"18","author":"Chan","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijpt.2025.101200_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/JS9.0000000000001997","article-title":"Treatment patterns and prognosis of patients with clear cell adenocarcinoma of the cervix: a population-based cohort study","volume":"111","author":"Li","year":"2025","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.ijpt.2025.101200_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jog.16300","article-title":"Retrospective analysis of treatment and prognosis for clear cell carcinoma of the uterine cervix: 15-year experience at a single institution","volume":"51","author":"Inomata","year":"2025","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"10.1016\/j.ijpt.2025.101200_bib7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/IGC.0000000000000992","article-title":"Clear cell carcinoma of the uterine cervix: a clinical and pathological analysis of 47 patients without intrauterine diethylstilbestrol exposure","volume":"27","author":"Yang","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijpt.2025.101200_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.532748","article-title":"Clear cell adenocarcinoma of uterine cervix: a single institution retrospective experience","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2025.101200_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ygyno.2008.02.007","article-title":"Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era","volume":"109","author":"Thomas","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijpt.2025.101200_bib10","article-title":"Radioresistant, rare, recurrent, and radioinduced: 4Rs of hadrontherapy for patients selections","volume":"15","author":"Vischioni","year":"2025","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijpt.2025.101200_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijpt.2025.101200_bib12","unstructured":"US Department of Health and Human Services National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0."},{"issue":"6","key":"10.1016\/j.ijpt.2025.101200_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ctrv.2015.03.011","article-title":"The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant","volume":"41","author":"Reynders","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.ijpt.2025.101200_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2013.11.011","article-title":"Curative radiation therapy for locally advanced cervical cancer: brachytherapy is NOT optional","volume":"88","author":"Tanderup","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.ijpt.2025.101200_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11604-024-01566-8","article-title":"Phase I\/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy","volume":"42","author":"Ito","year":"2024","journal-title":"Jpn J Radiol"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21873\/cdp.10008","article-title":"Stereotactic body radiation therapy boost in patients with cervical cancer ineligible for brachytherapy","volume":"1","author":"Facondo","year":"2021","journal-title":"CDP"},{"issue":"9","key":"10.1016\/j.ijpt.2025.101200_bib17","first-page":"1278","article-title":"Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review","volume":"31","author":"Campitelli","year":"2021","journal-title":"Int\u00a0J\u00a0Gynecol\u00a0Cancer"},{"issue":"1","key":"10.1016\/j.ijpt.2025.101200_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13014-021-01877-4","article-title":"Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible","volume":"16","author":"Lee","year":"2021","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2025.101200_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/curroncol32030170","article-title":"A systematic review of SBRT boost for cervical cancer patients who cannot benefit from brachytherapy","volume":"32","author":"Gazsi","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijpt.2025.101200_bib20","first-page":"1","article-title":"External radiation and brachytherapy resource deficit for cervical cancer in India: call to action for treatment of all","volume":"5","author":"Chopra","year":"2019","journal-title":"J Glob Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2025.101200_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5114\/jcb.2022.119451","article-title":"An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma","volume":"14","author":"Okonogi","year":"2022","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"10.1016\/j.ijpt.2025.101200_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.radonc.2015.03.007","article-title":"Cervical cancer outcome prediction to high-dose rate brachytherapy using quantitative magnetic resonance imaging analysis of tumor response to external beam radiotherapy","volume":"115","author":"Minkoff","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2025.101200_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijrobp.2024.10.003","article-title":"Carbon-ion radiation therapy for adenocarcinoma of the uterine cervix: clinical outcomes of a Multicenter Prospective Registry-Based Study in Japan (2016-2020)","volume":"121","author":"Murata","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jrr\/rrz106","article-title":"Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8+ lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study","volume":"61","author":"Miyasaka","year":"2020","journal-title":"J Radiat Res"},{"issue":"10","key":"10.1016\/j.ijpt.2025.101200_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jfma.2018.07.002","article-title":"Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: a propensity score matching study","volume":"117","author":"Yin","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ijpt.2025.101200_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2019.01.006","article-title":"Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables","volume":"135","author":"Gadducci","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2014.08.018","article-title":"Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation","volume":"135","author":"Rose","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijpt.2025.101200_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/aogs.12383","article-title":"Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma\/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy","volume":"93","author":"Chen","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/cam4.1305","article-title":"Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1\/2 clinical trial (Protocol 1001)","volume":"7","author":"Okonogi","year":"2018","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.ijpt.2025.101200_bib30","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/cancers13112713","article-title":"Multi-institutional retrospective analysis of carbon-ion radiotherapy for patients with locally advanced adenocarcinoma of the uterine cervix","volume":"13","author":"Okonogi","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ijpt.2025.101200_bib31","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cancers12103022","article-title":"Carbon ion radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers"},{"issue":"1107","key":"10.1016\/j.ijpt.2025.101200_bib32","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190224","article-title":"Harnessing radiation to improve immunotherapy: better with particles?","volume":"93","author":"Durante","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijpt.2025.101200_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fonc.2018.00192","article-title":"Radiation-induced chromosomal aberrations and immunotherapy: micronuclei, cytosolic DNA, and interferon-production pathway","volume":"8","author":"Durante","year":"2018","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2020.09.041","article-title":"Reduction of lung metastases in a mouse osteosarcoma model treated with carbon ions and immune checkpoint inhibitors","volume":"109","author":"Helm","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ijpt.2025.101200_bib35","doi-asserted-by":"crossref","first-page":"633","DOI":"10.18632\/oncotarget.26551","article-title":"Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma","volume":"10","author":"Takahashi","year":"2019","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.ijpt.2025.101200_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molmed.2013.05.007","article-title":"Immunologically augmented cancer treatment using modern radiotherapy","volume":"19","author":"Durante","year":"2013","journal-title":"Trends Mol\u00a0Med"},{"key":"10.1016\/j.ijpt.2025.101200_bib37","first-page":"14","article-title":"ATM mutation and radiosensitivity: an opportunity in the therapy of mantle cell lymphoma","volume":"107","author":"Ahmed","year":"2016","journal-title":"Crit\u00a0Rev\u00a0Oncol Hematol"},{"issue":"24","key":"10.1016\/j.ijpt.2025.101200_bib38","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM","volume":"64","author":"Hickson","year":"2004","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ijpt.2025.101200_bib39","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1074\/jbc.M611605200","article-title":"Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break","volume":"282","author":"Chen","year":"2007","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.ijpt.2025.101200_bib40","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.3390\/cancers14246141","article-title":"Cancer and radiosensitivity syndromes: is impaired nuclear ATM kinase activity the primum movens?","volume":"14","author":"El Nachef","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijpt.2025.101200_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4143\/crt.2020.1247","article-title":"Increased radiosensitivity of solid tumors harboring ATM and BRCA1\/2 mutations","volume":"54","author":"Kim","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ijpt.2025.101200_bib42","first-page":"105","article-title":"Health risks for ataxia\u2010telangiectasia mutated heterozygotes: a systematic review, meta\u2010analysis and evidence\u2010based guideline","volume":"90","author":"Van Os","year":"2016","journal-title":"Clin\u00a0Genet"},{"issue":"5","key":"10.1016\/j.ijpt.2025.101200_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100709","article-title":"Germline pathogenic variants in patients with pancreatic ductal adenocarcinoma and extra-pancreatic malignancies: a nationwide database analysis","volume":"38","author":"Kryklyva","year":"2025","journal-title":"Mod Pathol"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025004639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518025004639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:05:13Z","timestamp":1772903113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518025004639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S2331518025004639"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.101200","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Tumor Control After Carbon Ion Radiation Therapy Boost in Locally Advanced Cervical Clear Cell Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2025.101200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101200"}}